EcoDrugPlus

Ensembl ID : ENSVVUG00000011074
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSVVUG00000002311
Gene Symbol: -
Cross references: -
102 Possible Orthologues:

Ensembl ID : ENSVVUG00000010706
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSVVUG00000010177
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSVVUG00000010170
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSVVUG00000017262
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSVVUG00000010683
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSVVUG00000002460
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSVVUG00000017799
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSVVUG00000017988
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSVVUG00000005902
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSVVUG00000020342
Gene Symbol: -
Cross references: -
257 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).